Hematology TimesMogamulizumab is ‘valuable’ option for CTCLFebruary 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsAML immune profiles correlate with relapse-free survivalFebruary 4, 2018AMLImmunotherapyLeukemia, Myelodysplasia, Transplantation
Hematology NewsMedPAC mulls boost to payments for E&M visitsFebruary 4, 2018Business of MedicinePractice Management
Oncology PracticeFirst-line ramucirumab nets small PFS benefit in gastric cancerJanuary 29, 2018GastroenterologyGastrointestinal Cancer
Oncology PracticePembrolizumab plus SBRT shows promise for advanced solid tumorsJanuary 27, 2018Immuno-oncologyBreast CancerLung CancerGenitourinary CancerGastroenterologyHead & Neck/Thyroid CancersGynecologic Cancer
Hematology NewsVIDEO: COMPASS shows stroke-clot aspiration noninferior to retrievalJanuary 26, 2018Thrombosis
Oncology PracticeExperimental PD-1/PARP inhibitor combo shows promise in solid tumorsJanuary 26, 2018Gynecologic CancerImmuno-oncology
Oncology PracticeCombination immunotherapy is active in dMMR/MSI-H metastatic colorectal cancerJanuary 26, 2018Immuno-oncologyGastroenterologyImmunotherapyGastrointestinal Cancer
Hematology NewsmIDH inhibitors could fill treatment gap in AMLJanuary 25, 2018AMLLeukemia, Myelodysplasia, Transplantation
Oncology PracticeCirculating tumor cell assay shows promise for colorectal cancer screeningJanuary 24, 2018GastroenterologyPreventive CareGI OncologyGastrointestinal Cancer
